Dubuque Bank & Trust’s Vertex Pharmaceuticals VRTX Stock Holding History

Dubuque Bank & Trust’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-17	Closed	-$3K	–	590
2019 Q1	$3K	Buy	+17	New	+$3.14K	﹤0.01%	632
2018 Q3	–	Sell	-7	Closed	-$1K	–	725
2018 Q2	$1K	Hold	7	–	–	﹤0.01%	685
2018 Q1	$1K	Buy	+7	New	+$1.14K	﹤0.01%	712
2016 Q1	–	Sell	-26	Closed	-$3K	–	710
2015 Q4	$3K	Buy	+26	New	+$3.14K	﹤0.01%	668
2013 Q4	–	Sell	-205	Closed	-$16K	–	440
2013 Q3	$16K	Hold	205	–	–	﹤0.01%	288
2013 Q2	$16K	Buy	+205	New	+$15.1K	﹤0.01%	253

Other funds holding VRTX

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Dubuque Bank & Trust's VRTX Position: Q2 2019 in Review

Dubuque Bank & Trust sold out of Vertex Pharmaceuticals (VRTX) in Q2 2019, closing a stake of 17 shares — an estimated $3K sold.

Dubuque Bank & Trust first reported a position in VRTX in Q2 2013 and held it in 6 quarters. The position peaked at $16K in Q3 2013. 716 funds tracked by Wall St. Rank hold VRTX as of Q2 2019.

Dubuque Bank & Trust reported no remaining Vertex Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
Dubuque Bank & Trust sold 17 Vertex Pharmaceuticals shares in Q2 2019, an estimated $3K.
Dubuque Bank & Trust first reported a position in Vertex Pharmaceuticals in Q2 2013 and held it in 6 quarters.
Dubuque Bank & Trust's Vertex Pharmaceuticals position peaked at $16K in Q3 2013.
716 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2019.

Based on Dubuque Bank & Trust's 13F filing for Q2 2019, filed 10 Jul 2019.